Micro Imaging Technology
California-based public company Micro Imaging Technology (MMTC) develops the MIT 1000, an AOAC-certified laser-based rapid microbial identification system for food safety and environmental labs. It is expanding into medical aesthetics and regenerative medicine through acquisitions of SaltMed/SaltFacial and Cellmyx.
- Company typePublic
- Founded2005
- HeadquartersSan Clemente, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Micro Imaging Technology does
Micro Imaging Technology, Inc. (MIT) is a California-based public company trading under the ticker MMTC that develops laser-based rapid microbial identification technology for laboratory use. Its flagship product, the MIT 1000, is an AOAC-certified system that uses 35 photo detectors arranged around a sample vial to collect light scattering intensities generated when bacterial cells intersect a laser beam, enabling identification of pathogenic bacteria within minutes of culturing. The system is sold to food safety testing laboratories as the primary customer segment, with environmental monitoring facilities as a secondary use case, replacing slower traditional culturing and identification methods.
Micro Imaging Technology firmographics
Firmographics- Name
- Micro Imaging Technology
- Legal name
- Micro Imaging Technology, Inc.
- Website
- https://micro-identification.com
- Company type
- Public
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- California-based public company Micro Imaging Technology (MMTC) develops the MIT 1000, an AOAC-certified laser-based rapid microbial identification system for food safety and environmental labs. It is expanding into medical aesthetics and regenerative medicine through acquisitions of SaltMed/SaltFacial and Cellmyx.
- Ownership category
- akta.pro rank
Micro Imaging Technology industry classification
Industry- Product category
- Laboratory Instrumentation
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)
- akta.pro secondary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
Keywords
Where Micro Imaging Technology is headquartered
LocationHeadquarters
- HQ city
- San Clemente
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Micro Imaging Technology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Laboratory Equipment Sales: Sale of MIT 1000 microbial identification instruments to laboratories and industrial facilities for pathogen detection and food safety testing.
- Consumables and Reagents: Ongoing consumables sales for the MIT 1000 system operation, including sample vials and identification reagents.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Micro Imaging Technology product offering
Product offeringCore offering
Micro Imaging Technology develops and sells the MIT 1000, an AOAC-certified, laser-based rapid microbial identification system that uses light scattering technology with 35 photo detectors to identify pathogenic bacteria within minutes after culturing. The company sells this laboratory instrument to food safety testing laboratories and environmental monitoring facilities, and has expanded its portfolio through acquisitions of SaltMed/SaltFacial (aesthetic products) and Cellmyx (regenerative medicine, FDA-cleared intelliFat BOD device).
Product overview
Micro Imaging Technology offers a portfolio combining proprietary microbial identification technology with acquired aesthetics and regenerative medicine products. The core offering is the MIT 1000, an AOAC-certified laser-based rapid microbial identification system for pathogenic bacteria detection. The company has expanded through strategic acquisitions: SaltMed/SaltFacial (December 2025) and Cellmyx (June 2026), which brings the FDA-cleared intelliFat® BOD™ device for orthopedic and cosmetic surgery applications. The combined portfolio is designed to enable expanded manufacturing and distribution nationally and worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- MIT 1000: AOAC-certified, laser-based rapid microbial identification system capable of identifying pathogenic bacteria in minutes.
Products and services
- MIT 1000 Rapid Microbial Identification System
- intelliFat BOD
- SaltMed/SaltFacial
Companies that use Micro Imaging Technology
Customer profileSegments2 records
Ideal customer profiles2 records
Micro Imaging Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Micro Imaging Technology partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- CellmyxcoreMicro Imaging Technology acquired Cellmyx, a 25-year-old FDA-registered manufacturer specializing in autologous adipose grafting and regenerative medicine. Cellmyx holds FDA 510(k) clearance for the intelliFat BOD device used in orthopedic and cosmetic surgery. This acquisition complements MIT's earlier purchase of SaltMed/SaltFacial, creating a combined portfolio that strengthens MIT's manufacturing and distribution capabilities nationally and worldwide.
- SaltMed/SaltFacialcoreMIT acquired SaltMed/SaltFacial in December 2025, establishing a foundation in the aesthetics and regenerative medicine space prior to the Cellmyx acquisition.
Scale indicators3 records
Recent moves4 records
Expansion highlights5 records
Micro Imaging Technology competitors and assessment
Company assessmentDirect peers
- Bio-Rad Laboratories: Offers the iQ-Check PCR-based pathogen detection systems and other microbiology workflows for the food-safety testing market. Comparable customer segment to MIT 1000 with similar goal of rapid, certified pathogen identification.
- Bruker Corporation: Maker of the MALDI Biotyper, the dominant rapid microbial identification platform in clinical and food-safety labs. Directly competes with the MIT 1000 on speed and accuracy for pathogen ID, but uses mass spectrometry rather than light scattering.
- Charles River Laboratories: Provides end-to-end microbial identification, QC, and lab services to food, cosmetic, and pharmaceutical manufacturers. Comparable to MIT's target customer base for outsourced and in-house food-safety microbial workflows.
- bioMérieux (Industrial Microbiology): Industrial division of bioMérieux offering rapid microbial testing for food and beverage producers. Direct overlap with the MIT 1000's food-safety value proposition of faster, AOAC-equivalent identification.
Broad incumbents
- bioMérieux: Global leader in microbiology diagnostics (VITEK, BioBall) serving clinical and industrial food-safety labs. Highly comparable to MIT 1000's microbial identification mission but at vastly larger scale with broader organism libraries and installed base.
- Becton, Dickinson and Company (BD): Major supplier of microbiology diagnostics and lab automation (BD Phoenix, BD MAX) to clinical and industrial labs. Overlaps with MIT 1000 in food-safety and environmental testing customer base.
- Thermo Fisher Scientific: Diversified life-sciences instrument vendor (MicroSEQ, Applied Biosystems) with food-safety and clinical microbiology offerings. Overlaps with MIT 1000 on microbial ID workflows, especially in industrial and food-testing labs.
Others
- MilliporeSigma (Sigma-Aldrich / Merck KGaA Life Science): Supplies microbiology consumables, media, and identification reagents used by food-safety and clinical labs. Comparable as a consumables/reagents ecosystem participant adjacent to MIT 1000's recurring-revenue business.
Emerging players
- Accelerate Diagnostics: Developer of rapid phenotypic antimicrobial susceptibility testing (AST) and identification platforms for clinical microbiology. Comparable to MIT 1000's value proposition of minutes-to-hours vs days for traditional methods, though focused on clinical ID/AST.
- T2 Biosystems: Developed T2 Magnetic Resonance-based rapid diagnostics for bloodstream and other infections. Comparable emerging-player profile and 'minutes-to-hours' value proposition to MIT 1000, though focused on clinical sepsis.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Micro Imaging Technology social profiles
Digital presenceMicro Imaging Technology compliance and trust
Trust signalCompliance1 record
Micro Imaging Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Micro Imaging Technology leadership team
Management profileNumber of profiles
Micro Imaging Technology subsidiaries and ownership
Company hierarchySubsidiaries2 records
Micro Imaging Technology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Micro Imaging Technology M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Micro Imaging Technology
What does Micro Imaging Technology do?
Micro Imaging Technology develops and sells the MIT 1000, an AOAC-certified, laser-based rapid microbial identification system that uses light scattering technology with 35 photo detectors to identify pathogenic bacteria within minutes after culturing. The company sells this laboratory instrument to food safety testing laboratories and environmental monitoring facilities, and has expanded its portfolio through acquisitions of SaltMed/SaltFacial (aesthetic products) and Cellmyx (regenerative medicine, FDA-cleared intelliFat BOD device).
Is Micro Imaging Technology a public or private company?
Micro Imaging Technology is a public company. It is classified as public and is currently operating.
When was Micro Imaging Technology founded?
Micro Imaging Technology was founded in 2005. It employs 1 to 10 people.
Where is Micro Imaging Technology based?
Micro Imaging Technology is headquartered in San Clemente, United States, in the North America region.
How does Micro Imaging Technology make money?
Two revenue lines are on record. Laboratory Equipment Sales are the primary driver. The others are consumables and Reagents.
Who are Micro Imaging Technology's main competitors?
Direct peers on record are Bio-Rad Laboratories, Bruker Corporation, Charles River Laboratories and bioMérieux (Industrial Microbiology). Broad incumbents are bioMérieux, Becton, Dickinson and Company (BD) and Thermo Fisher Scientific. MilliporeSigma (Sigma-Aldrich / Merck KGaA Life Science) is listed as an others. Emerging players are Accelerate Diagnostics and T2 Biosystems.
Does Micro Imaging Technology have an API?
No public API is recorded for Micro Imaging Technology.
What industry is Micro Imaging Technology in?
Micro Imaging Technology's product category is Laboratory Instrumentation. Its primary akta.pro industry code is HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels), with a secondary code of HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 334516 and its SIC code is 3826.